"The
Pharmaceutical Market: United Arab Emirates "is
the latest addition to MarketResearchReports.Biz industry research
reports collection.
OVERVIEW OF THE
PHARMACEUTICAL MARKET IN UNITED ARAB EMIRATES
The
United Arab Emirates'healthcare and pharmaceutical markets continue
to be thestrongest in the region.Its growth prospects arestrong -we
forecast high single-digit CAGRsover the course of our 10-year
forecast period. Several factors are driving growth: incomes are
high, as isthe UAE's expatriate population.These elements combine to
increase private healthcare expenditure and demand for innovative
drugs.
Local
drug production facilities are also gaining strength, with domestic
player Julphar opening a new factory, and multinational drug firms
are also entering the market. In addition, there areplans forseveral
new hospital and healthcare facilities,whichwill boost future demand
for pharmaceuticals. The UAE's appeal as a medical tourism
destination is another driver of growth.Wethereforeremain optimistic
aboutthegrowth potentialof the United Arab Emirates
(UAE)'spharmaceuticalandhealthcaremarkets.
View Report at :
http://www.marketresearchreports.biz/analysis/212638
Headline Expenditure
Projections
- Pharmaceuticals: AED5.56bn (US$1.51bn) in 2011 to AED5.72bn (US$1.56bn) in 2012; +2.9% in local currency and US dollar terms. Forecastunchanged from Q412.
- Healthcare: AED46.44bn (US$12.64bn) in 2011 to AED52.13bn (US$14.20bn) in 2012; +12.2% in local currency terms and +12.3% in US dollar terms. Forecastbroadly unchanged from Q412.
- Medical devices: AED1.87bn (US$508mn) in 2011 to AED2.05bn (US$559mn) in 2012; +10.0% in local currency terms and +10.1% in US dollar terms. Forecastbroadly unchanged from Q412.
Business Environment Rating
In
Q1 13, the UAE remains the most attractive market in BMI's Middle
East and Africa (MEA) Pharmaceutical Risk/Reward Ratings (RRR)
matrix, with its composite score unchanged at 58.3 out of 100. The
country has a favourable medium-term pharmaceutical market growth
forecast.
Competitive Landscape
The
competitive landscape section provides comparative company analyses
and rankings by US$ sales and % share of total sales - for the total
pharmaceutical sector, as well as the OTC, generics, and distribution
sub-sectors.
Download Sample copy of this
Report at :
http://www.marketresearchreports.biz/sample/sample/212638
Table
of Contents
BMI
Industry View7
SWOT9
Business
Environment11
Economic12
Political13
Industry
Forecast14
Pharmaceutical
Market Forecast14
Table:
Pharmaceutical Sales Indicators 2009-201715
Healthcare
Market Forecast16
Table:
Healthcare Expenditure Indicators 2009-201718
Table:
Healthcare Governmental Indicators 2009-201718
Table:
Healthcare Private Indicators 2009-201719
Prescription
Market Forecast19
Table:
UAE Healthcare Demand Split By Therapeutic Area20
Table:
Prescription Drug Sales Indicators 2009-201722
Patented
Drug Market Forecast22
Table:
Patented Drug Market Indicators, 2009-201723
Generic
Drug Market Forecast23
Table:
Generic Drug Sales Indicators, 2009-201724
OTC
Medicine Market Forecast25
Table:
OTC Medicine Sales Indicators, 2009-201726
Pharmaceutical
Trade Forecast27
Table:
Exports And Imports Indicators, 2009-201728
Browse
Press Releases by Prweb :
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment